4 active not recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Active not recruiting 4 |
Follow Malabsorption Syndromes: new trials by email Literature Review of Malabsorption Syndromes trials Research Report on Malabsorption Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome Glepaglutide 10 mg - Short Bowel Syndrome (SBS) | Phase 3 | Active not recruiting | Zealand Pharma | 28 | 2025-12-11 | 2026-07-30 |
| A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome Teduglutide - Short Bowel Syndrome | Phase 3 | Active not recruiting | Takeda | 13 | 2025-06-26 | 2026-09-08 |
| Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition PJ009, PJ009 Placebo - Short Bowel Syndrome | Phase 3 | Active not recruiting | Chongqing Peg-Bio Biopharm Co., Ltd. | 72 | 2024-09-03 | 2026-10-22 |
| Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. Apraglutide - Short Bowel Syndrome | Phase 3 | Active not recruiting | VectivBio AG | 158 | 2021-07-13 | 2025-07-02 |
Short Bowel Syndrome (4) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Intestinal Failure (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Postoperative Complications (1)
Digestive System Diseases (3) · Gastrointestinal Diseases (3) · Intestinal Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Postoperative Complications (3) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
ALX-0600 (1) · Glucagon-Like Peptide 2 (1) · apraglutide (1) · teduglutide (1)
Chongqing Peg-Bio Biopharm Co., Ltd. (1) · Takeda (1) · VectivBio AG (1) · Zealand Pharma (1)
Belgium (2) · China (2) · France (2) · Germany (2) · Poland (2) · United Kingdom (2) · United States (2) · Argentina (1) · Canada (1) · Czechia (1) · Denmark (1) · Hungary (1) · Israel (1) · Italy (1) · Japan (1)
Huanlong Qin (1) · Tomasz Masior (1)
2025 (1)